CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SINPAIN focuses on developing a novel therapy for knee osteoarthritis using small interfering RNA (siRNA) technology combined with innovative delivery systems. The project aims to alleviate pain and slow disease progression through targeted treatments and a personalized decision-making tool based on machine learning.
According to the WHO Osteoarthritis (OA) is one major course of years lived with disability in the elderly and considered a high burden disease, which makes it a research priority in Europe.
There is no cure for OA and SoA treatments need to be reconsidered.
Current pharmacological interventions consist of analgesic, anti-inflammatory drugs as well as intraarticular steroids and hyaluronic acid (IA-HA) with moderate efficacy and associated long-term side effects.
New medications are thus needed…
FUNDACION CIDETEC
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
ASOCIACION INSTITUTO BIOGIPUZKOA
Spain, DONOSTIA-SAN SEBASTIAN
Type: Research institute
Activity type: Research Organisations
SME: No
France, Marseille
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, Saarbrucken
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Barcelona
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
